W975 (Divalproex Sodium Delayed-Release 500 mg)

Pill with imprint W975 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 500 mg. It is supplied by Wockhardt USA.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy; cyclothymic disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for W975

Divalproex Sodium Delayed-Release

Imprint:

W975

Strength:

500 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Wockhardt USA

Inactive Ingredients:

silicon dioxide
microcrystalline cellulose
corn starch
povidone
croscarmellose sodium
glyceryl behenate
magnesium silicate
hypromelloses
polyethylene glycol
polyvinyl alcohol
polysorbate 80
methacrylic acid - ethyl acrylate copolymer (1:1) type a
triethyl citrate
sodium bicarbonate
sodium lauryl sulfate
dimethicone
titanium dioxide
Note: Inactive ingredients may vary.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer